Abstract
The pre-operative utilisation of indwelling urinary catheters (IDCs) has become standard orthopaedic practice in patients with hip fractures with the aim to minimise the incidence of post-operative bladder dysfunction which occurs due to administration of analgesia and anaesthesia [1]. Despite the practical benefits of IDC insertion, there are well-documented associated risks which include hospital-acquired urinary tract infection (UTI), which is positively correlated with its duration in situ-estimated to be around 5-10% each catheter day after the first 48 hours of catheterisation [2]. Hospital-acquired UTIs have significant patient and healthcare costs, resulting in prolonged hospital stay, bacteraemia, prosthetic joint infections, and death [1].
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
